Evidence map›Paper›PMID 25012662›Full record

ArticleThe Journal of biological chemistry2014

The molecular mechanism of eukaryotic elongation factor 2 kinase activation.

Clint D J Tavares, Scarlett B Ferguson, David H Giles, Qiantao Wang, Rebecca M Wellmann, John P O'Brien, Mangalika Warthaka, Jennifer S Brodbelt, Pengyu Ren, Kevin N Dalby

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. ADP enhances the allosteric activation of eukaryotic elongation factor 2 kinase by calmodulin.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Clint D J TavaresFrom the Graduate Program in Cell and Molecular Biology, the Division of Medicinal Chemistry, College of Pharmacy, clinttavares@utexas.edu.
Scarlett B Fergusonthe Division of Medicinal Chemistry, College of Pharmacy.
David H Gilesthe Division of Medicinal Chemistry, College of Pharmacy.
Qiantao Wangthe Division of Medicinal Chemistry, College of Pharmacy, the Department of Biomedical Engineering, Cockrell School of Engineering, and.
Rebecca M Wellmannthe Division of Medicinal Chemistry, College of Pharmacy.
John P O'Brienthe Department of Chemistry and Biochemistry, College of Natural Sciences, University of Texas, Austin, Texas 78712.
Mangalika Warthakathe Division of Medicinal Chemistry, College of Pharmacy.
Jennifer S Brodbeltthe Department of Chemistry and Biochemistry, College of Natural Sciences, University of Texas, Austin, Texas 78712.
Pengyu Renthe Department of Biomedical Engineering, Cockrell School of Engineering, and.
Kevin N DalbyFrom the Graduate Program in Cell and Molecular Biology, the Division of Medicinal Chemistry, College of Pharmacy, dalby@austin.utexas.edu.
The University of Texas at Austin · US

Funding

DEVELOPMENT OF A NEXT-GENERATION NUCLEIC ACID FORCE FIELDR01GM106137 · NIGMS · WASHINGTON UNIVERSITY · PI JAY PONDER, Pengyu Ren · 2013 to 2026
$3.5M
Mechanism and Specificity of MAP KinasesR01GM059802 · NIGMS · UNIVERSITY OF TEXAS AUSTIN · PI DALBY, KEVIN N · 2001 to 2011
$2.3M
UV Photodissociation for Acidic and Basic Proteome CharacterizationR21GM099028 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI BRODBELT, JENNIFER S. · 2011 to 2012
$384k
NIGMS NIH HHS GM106137NIGMS NIH HHS GM59802NIGMS NIH HHS R01 GM059802NIGMS NIH HHS R01 GM106137NIGMS NIH HHS R21 GM099028
6 · The paper itself

Abstract

Calmodulin (CaM)-dependent eukaryotic elongation factor 2 kinase (eEF-2K) impedes protein synthesis through phosphorylation of eukaryotic elongation factor 2 (eEF-2). It is subject to complex regulation by multiple upstream signaling pathways, through poorly described mechanisms. Precise integration of these signals is critical for eEF-2K to appropriately regulate protein translation rates. Here, an allosteric mechanism comprising two sequential conformations is described for eEF-2K activation. First, Ca(2+)/CaM binds eEF-2K with high affinity (Kd(CaM)(app) = 24 ± 5 nm) to enhance its ability to autophosphorylate Thr-348 in the regulatory loop (R-loop) by > 10(4)-fold (k(auto) = 2.6 ± 0.3 s(-1)). Subsequent binding of phospho-Thr-348 to a conserved basic pocket in the kinase domain potentially drives a conformational transition of the R-loop, which is essential for efficient substrate phosphorylation. Ca(2+)/CaM binding activates autophosphorylated eEF-2K by allosterically enhancing k(cat)(app) for peptide substrate phosphorylation by 10(3)-fold. Thr-348 autophosphorylation results in a 25-fold increase in the specificity constant (k(cat)(app)/K(m)(Pep-S) (app)), with equal contributions from k(cat)(app) and K(m)(Pep-S)(app), suggesting that peptide substrate binding is partly impeded in the unphosphorylated enzyme. In cells, Thr-348 autophosphorylation appears to control the catalytic output of active eEF-2K, contributing more than 5-fold to its ability to promote eEF-2 phosphorylation. Fundamentally, eEF-2K activation appears to be analogous to an amplifier, where output volume may be controlled by either toggling the power switch (switching on the kinase) or altering the volume control (modulating stability of the active R-loop conformation). Because upstream signaling events have the potential to modulate either allosteric step, this mechanism allows for exquisite control of eEF-2K output.

Indexed as

Amino Acid SequenceCalciumCalmodulinCell Line, TumorElongation Factor 2 KinaseEnzyme ActivationHumansKineticsMolecular Sequence DataMutagenesis, Site-DirectedPhosphorylationProtein BiosynthesisSequence Homology, Amino AcidSubstrate SpecificityThreonineCalciumCalmodulinEEF2K protein, humanElongation Factor 2 KinaseThreonineAllosteric RegulationCalciumCalmodulin (CaM)CaMK-IIIeEF-2eEF-2KPhosphate-binding PocketPhosphorylationThr-348Translation

Identifiers

PMID25012662
PMCPMC4156036
OpenAlexW2055127446

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.